SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-048719
Filing Date
2021-09-20
Accepted
2021-09-20 06:06:51
Documents
3
Period of Report
2021-09-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea147643-6k_alteritythera.htm 6-K 11982
2 PRESENTATION OF NEW BIOMARKER DATA AT SCIENTIFIC CONGRESS ea147643ex99-1_alteritythera.htm EX-99.1 17930
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4258
  Complete submission text file 0001213900-21-048719.txt   37016
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 211261981
SIC: 2834 Pharmaceutical Preparations